Primary Amyloidosis

Primary Amyloidosis is the indication for 7 drugs in DrugBank. It is covered by 7 curated, structured indications.

Also known as: Primary Systemic Amyloidosis · Primary Systemic Amyloidosis (AL) · AL Amyloidosis · Light-Chain Amyloidosis · Primary Amyloidosis of Light Chain Type
Classified under: Disease and Non-Disease Concepts, Unclassified
Hemic and Lymphatic Diseases
Immune System Diseases
Neoplasms
Indicated drugs: Bortezomib
Cyclophosphamide
Daratumumab
Dexamethasone
Hyaluronidase (human recombinant)
Lenalidomide
Thalidomide

Resolves to

Vocabularies

MeSHM000630238ICD-10E85.81SNOMED CT128817004MedDRA10036673UMLSC0268381

What you can answer from here — as of October 22, 2026

7Indicated drugsWith each drug's targets and mechanism

Listed above

7Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

208Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Primary Amyloidosis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.